Prostate Cancer Awareness Month: Unlocking the Power of Immunotherapy to Combat a Common Men’s Cancer
September 06, 2024
Alexandra Bartlett, Ph.D., discusses her research in a mouse model to develop nontoxic immunotherapy strategies that address ‘on-target, off-tumor’ toxicity among patients with prostate cancer. She says, “If the treatment is too toxic, it does not matter if it is effective at shrinking tumors.”